Customer Q&A: Novartis

Novartis has a rich history of investing in the most promising frontiers of science, the most exciting innovations in the business of medicine, and the most significant healthcare needs. As the industry faces acute disruption, the company’s prescription for ongoing success hinges on APIs and microservices. Pascal Bouquet, Global Head of Architecture for Drug Development, answers a few questions about how digital transformation is moving Novartis forward.  

Previous Asset
Is API complexity holding you back?
Is API complexity holding you back?

Break free with centralized API visibility, control, and reuse across multiple vendors, gateways, and clouds

Next Asset
Digital transformation survival guide Part 4
Digital transformation survival guide Part 4

The future is open: create your digital destiny by giving teams a central place to unlock the business valu...